[
  {
    "ts": null,
    "headline": "KMTS, Biobeat Partner to Expand Diagnostic Insight in Cardiac Recovery",
    "summary": "Kestra teams up with Biobeat in an exclusive deal, investing $5M to add continuous blood pressure monitoring to the ASSURE WCD during cardiac recovery.",
    "url": "https://finnhub.io/api/news?id=ea68f29940574d40b04d4c41b137eaaf3b65efe5a1a2e740cb9d8626397e71a1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768406700,
      "headline": "KMTS, Biobeat Partner to Expand Diagnostic Insight in Cardiac Recovery",
      "id": 138114766,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Kestra teams up with Biobeat in an exclusive deal, investing $5M to add continuous blood pressure monitoring to the ASSURE WCD during cardiac recovery.",
      "url": "https://finnhub.io/api/news?id=ea68f29940574d40b04d4c41b137eaaf3b65efe5a1a2e740cb9d8626397e71a1"
    }
  },
  {
    "ts": null,
    "headline": "Reasons to Retain TransMedics Stock in Your Portfolio for Now",
    "summary": "TMDX gains momentum as OCS technology, a robust pipeline and strong Q3 results fuel growth, though gross margin pressure tempers the outlook.",
    "url": "https://finnhub.io/api/news?id=62a6eb7e86e65b341cc1db72c322ed960ef43ab9106bc6bb4634fcf6605b62ee",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768405680,
      "headline": "Reasons to Retain TransMedics Stock in Your Portfolio for Now",
      "id": 138113253,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "TMDX gains momentum as OCS technology, a robust pipeline and strong Q3 results fuel growth, though gross margin pressure tempers the outlook.",
      "url": "https://finnhub.io/api/news?id=62a6eb7e86e65b341cc1db72c322ed960ef43ab9106bc6bb4634fcf6605b62ee"
    }
  },
  {
    "ts": null,
    "headline": "Baxter Unveils Dynamo Smart Stretcher to Improve Hospital Safety",
    "summary": "BAX introduces its Dynamo Series smart stretcher, aiming to boost hospital safety and reduce patient transfers.",
    "url": "https://finnhub.io/api/news?id=b89aaa164d39860cc73a5515dc49703a7c4f661d1a3189aed41cb83fb458a97b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768405440,
      "headline": "Baxter Unveils Dynamo Smart Stretcher to Improve Hospital Safety",
      "id": 138113254,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "BAX introduces its Dynamo Series smart stretcher, aiming to boost hospital safety and reduce patient transfers.",
      "url": "https://finnhub.io/api/news?id=b89aaa164d39860cc73a5515dc49703a7c4f661d1a3189aed41cb83fb458a97b"
    }
  },
  {
    "ts": null,
    "headline": "The Zacks Analyst Blog Highlights AngioDynamics, Boston Scientific and Medtronic",
    "summary": "AngioDynamics shows how product mix shifts toward higher-margin Med Tech platforms are quietly reshaping earnings power across medtech stocks.",
    "url": "https://finnhub.io/api/news?id=ef6d39128fa4e053c6535b303cbf5ccf0a2d252984e593a0c464242fa55b5eb8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768403580,
      "headline": "The Zacks Analyst Blog Highlights AngioDynamics, Boston Scientific and Medtronic",
      "id": 138113255,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "AngioDynamics shows how product mix shifts toward higher-margin Med Tech platforms are quietly reshaping earnings power across medtech stocks.",
      "url": "https://finnhub.io/api/news?id=ef6d39128fa4e053c6535b303cbf5ccf0a2d252984e593a0c464242fa55b5eb8"
    }
  },
  {
    "ts": null,
    "headline": "Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now?",
    "summary": "EW benefits from strong TAVR and TMTT momentum, but macro pressures and FX headwinds cloud the near-term outlook.",
    "url": "https://finnhub.io/api/news?id=028621b8fa3bb06f5d0e8bd5efc4c1e4ffcd2b3284c15cab949231ad89f35fd3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768395000,
      "headline": "Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now?",
      "id": 138111962,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "EW benefits from strong TAVR and TMTT momentum, but macro pressures and FX headwinds cloud the near-term outlook.",
      "url": "https://finnhub.io/api/news?id=028621b8fa3bb06f5d0e8bd5efc4c1e4ffcd2b3284c15cab949231ad89f35fd3"
    }
  },
  {
    "ts": null,
    "headline": "Should You Continue to Hold Thermo Fisher Stock in Your Portfolio Now?",
    "summary": "TMO ramps up acquisitions and product launches to drive growth, but heavy debt and currency headwinds raise questions for long-term holders.",
    "url": "https://finnhub.io/api/news?id=f88809bce847ae4f5c95e369c799ece3d31daebe8ae4731563bda2edfc8c7ceb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768393140,
      "headline": "Should You Continue to Hold Thermo Fisher Stock in Your Portfolio Now?",
      "id": 138111222,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "TMO ramps up acquisitions and product launches to drive growth, but heavy debt and currency headwinds raise questions for long-term holders.",
      "url": "https://finnhub.io/api/news?id=f88809bce847ae4f5c95e369c799ece3d31daebe8ae4731563bda2edfc8c7ceb"
    }
  },
  {
    "ts": null,
    "headline": "Pulling back 3.7% this week, Boston Scientific's NYSE:BSX) five-year decline in earnings may be coming into investors focus",
    "summary": "The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...",
    "url": "https://finnhub.io/api/news?id=9e9e9c7b6a145c73db1a43b96844445420bb0490d72020ed9b3d825a8db9fb66",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768388417,
      "headline": "Pulling back 3.7% this week, Boston Scientific's NYSE:BSX) five-year decline in earnings may be coming into investors focus",
      "id": 138110504,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...",
      "url": "https://finnhub.io/api/news?id=9e9e9c7b6a145c73db1a43b96844445420bb0490d72020ed9b3d825a8db9fb66"
    }
  },
  {
    "ts": null,
    "headline": "JPM26: Boston Scientific expects strong PFA performance for 2026 and beyond",
    "summary": "Boston Scientific expects incredibly high growth for its pulsed field ablation (PFA) devices, driven by increased usage of its existing catheters.",
    "url": "https://finnhub.io/api/news?id=f2cf6aca2c89e259355cc0f086ba53263075b33634e68ad245c6431aefde54a6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768348806,
      "headline": "JPM26: Boston Scientific expects strong PFA performance for 2026 and beyond",
      "id": 138092370,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific expects incredibly high growth for its pulsed field ablation (PFA) devices, driven by increased usage of its existing catheters.",
      "url": "https://finnhub.io/api/news?id=f2cf6aca2c89e259355cc0f086ba53263075b33634e68ad245c6431aefde54a6"
    }
  }
]